A Bill to require the Secretary of State to take steps to secure licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.
Sponsors 1
Latest activity
2nd reading (2R) — Commons07 Nov 2014
Quick stats
- Stages
- 2
- Publications
- 1
- Amendments
- 0
- First event
- 02 Jul 2014
- Last update
- 30 Mar 2015
- Sessions
- #27
Stages 2
- 1R1st reading — Commons02 Jul 2014
- 2R2nd reading — Commons07 Nov 2014
Source: bills.parliament.uk ↗